Hydrogen Therapy Boosts Immune System to Fight Cancer in Mice
Synergistic Calcium Overload and Hydrogen Release Potentiate Robust Antitumor Immunity
Research hubs: Immune System
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Xueqi Liang, Zhen Liu, Nan Wang, Xiao-Kun Ouyang, Junhong Ling
- Journal
- Advanced Healthcare Materials
- Year
- 2026
- DOI
- 10.1002/adhm.202505332
- PMID
- 41580925
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Cancer
- Body System
- Immune System
This research was done on cells or tissue in a lab, not in people or animals.
TL;DR
A calcium-based nanoparticle that releases hydrogen enhanced anti-tumor immune responses and slowed tumor growth by improving the tumor immune environment.
Key Finding
In mouse tumors, a nanoparticle releasing both calcium and hydrogen gas together reduced tumor growth more effectively than either approach alone by triggering immune cell activation and reducing tumor-protective inflammation.
Summary
Researchers developed a nanoparticle (tiny engineered particle) called Ca@CMPN that releases calcium and hydrogen gas inside tumor cells. When tested in mice, this nanoparticle caused cancer cells to die in a way that triggered the immune system to attack remaining tumors, while hydrogen gas reduced harmful inflammation in the tumor environment. The combination of calcium overload and hydrogen appeared to work together to slow tumor growth and activate immune cells.
Practical Takeaway
This is early-stage laboratory research in mice only, not human studies. While the results suggest hydrogen gas may have immune-supporting properties when combined with other therapies, this nanoparticle platform is not available as a consumer product and much more research is needed before any conclusions about hydrogen water for cancer could be drawn.
Abstract (excerpt)
ABSTRACT Immunogenic cell death (ICD) induced by calcium overload holds great promise for reversing the immunosuppressive tumor microenvironment (TME) and improving cancer immunotherapy. However, achieving sustained calcium dysregulation remains a major challenge. Herein, we report a novel…